Document Detail


Reduction of hepatotoxicity of tumor necrosis factor in isolated hepatic perfusion by administration of glucocorticoid as well as lipopolysaccharide.
MedLine Citation:
PMID:  10769706     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The application of an isolation procedure with tumor necrosis factor (TNF) to the liver is quit attractive, however, one of problems to overcome is reducing the toxicity to the liver caused by high doses of TNF. MATERIALS AND METHODS: Rats underwent isolated hepatic perfusion (IHP) with TNF and pre-treatment of subcutaneous administration of dexamethasone (4 mg/kg) and/or intradermal administration of LPS (50 micrograms/rat). After a 10 min perfusion, a washout procedure was performed for 5 min, after which isolation was terminated. RESULTS: SD or Wister rats and F344 rats tolerated up to 120 mg/rat or 4 micrograms/rat, respectively. Dexamethasone and/or LPS was tolerated at 40 micrograms/rat of TNF in F344 rat and showed a significant reduction of hepatotoxicity, and indicated histologically the suppression of ballooning and of necrosis during and after perfusion by TNF. CONCLUSION: We propose new a protocol for IHP as follows: 1. the intradermal administration of LPS for protection against toxicity of TNF, 2. IHP with TNF-SAM2, a mutain of TNF-alpha, having less toxicity than conventional TNF-alpha, and 3. simultaneous perfusion with chemotherapeutic agents such as 5-fluorouracil (5-FU).
Authors:
T Nakamoto; H Inagawa; K Takagi; K Tashiro; H Yoshimura; T Nishizawa; T Honda; J Kanou; Y Muto; G Soma
Related Documents :
3743526 - Evaluation of heparin toxicity in the isolated and perfused rat liver.
17394146 - Preservation of steatotic livers: a comparison between cold storage and machine perfusi...
9881656 - Hepatic disposition characteristics of recombinant human interleukin-11 (rhil-11) in th...
7552956 - Effect of specimen preparation method on relative volume of the microvasculature--a lig...
6087946 - Localization of transferrin and transferrin receptors in rat testes.
2993836 - Urinary pco2 as an index of collecting duct hydrogen ion secretion during chronic hyper...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  20     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    2000 Jan-Feb
Date Detail:
Created Date:  2000-05-01     Completed Date:  2000-05-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  623-8     Citation Subset:  IM    
Affiliation:
Department of Clinical Medicine, Takano Hospital, Kumamoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Dexamethasone / administration & dosage*
Humans
Lipopolysaccharides / administration & dosage*
Liver / drug effects*,  enzymology,  pathology
Male
Middle Aged
Rats
Rats, Inbred F344
Rats, Sprague-Dawley
Rats, Wistar
Tumor Necrosis Factor-alpha / adverse effects*
Chemical
Reg. No./Substance:
0/Lipopolysaccharides; 0/Tumor Necrosis Factor-alpha; 50-02-2/Dexamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics of isolated hepatic perfusion with high dose tumor necrosis factor in rat model.
Next Document:  Relationship between microvessel quantification and inducibility of endogenous tumor necrosis factor...